Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening.
Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening.
复制标题
DOI:
10.1021/jm900277z
复制
发表时间:
2009-08-27
影响因子:
7.3
通讯作者:
Holliday LS
中科院分区:
文献类型:
--
作者:
Ostrov DA;Magis AT;Wronski TJ;Chan EK;Toro EJ;Donatelli RE;Sajek K;Haroun IN;Nagib MI;Piedrahita A;Harris A;Holliday LS
An interaction between the B2 subunit of vacuolar H+-ATPase (V-ATPase) and microfilaments is required for osteoclast bone resorption. An atomic homology model of the actin binding site on B2 was generated and molecular docking simulations were performed. Enoxacin, a fluoroquinolone antibiotic, was identified and in vitro testing demonstrated that enoxacin blocked binding between purified B2 and microfilaments. Enoxacin dose dependently reduced the number of osteoclasts differentiating in mouse marrow cultures stimulated with 1,25-dihydroxyvitamin D3, as well as markers of osteoclast activity, and the number of resorption lacunae formed on bone slices. Enoxacin inhibited osteoclast formation at concentrations where osteoblast formation was not altered. In summary, enoxacin is a novel small molecule inhibitor of osteoclast bone resorption that acts by an unique mechanism and is therefore an attractive lead molecule for the development of a new class of antiosteoclastic agents.
登录
查看更多内容
DOI:
10.1097/spc.0b013e32830baac2
发表时间:
2008-09-01
影响因子:
2.1
作者:
Lipton, Allan;Jun, Susie
通讯作者:
Jun, Susie
影响因子:
4.8
作者:
Lee, BS;Gluck, SL;Holliday, LS
通讯作者:
Holliday, LS
影响因子:
4.8
作者:
HOLLIDAY, LS;DEAN, AD;GLUCK, SL
通讯作者:
GLUCK, SL
影响因子:
4.8
作者:
Holliday, LS;Welgus, HG;Gluck, SL
通讯作者:
Gluck, SL
影响因子:
3.3
作者:
Rubinstein, E
通讯作者:
Rubinstein, E